TCTC Group

TCTC is a full service CRO headquartered in Manchester, United Kingdom. Formed in 2002, TCTC is a privately owned full-service clinical research provider. Our philosophy is one of teamwork, positivity, communication, responsibility and adding value. TCTC targets biotech clients with medium size clinical trials and novel products which often do not have a classical road map to the market. TCTC ran the clinical programme for the first gene therapy to be approved in the Western World. Larger Global CROs prioritise large studies, for good business reasons. However, this approach sometimes disadvantages their clients with smaller trials who equally need to complete their clinical trials in a timely manner. TCTC has enjoyed a high level of repeat business from existing clients. The Clinical Trial Company™ has been inspected by the UK MHRA and has a current certificate of compliance. There were no critical or major findings observed during the inspection. In the last published report of GCP findings by the MHRA 95% of CROs had at least on critical and/or major finding. TCTC operates an ISO 9001-2015 quality system which further supports our company philosophy of performing high-quality clinical trials for our clients. In 2012 TCTC were awarded the Queen's Award for Enterprise.